カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の患者用生体内線量測定（IVD）システム市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Patient In-vivo Dosimetry (IVD) System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO18217）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO18217
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の患者用生体内線量測定（IVD）システム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

患者用生体内線量測定（IVD）システム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の患者用生体内線量測定（IVD）システムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

患者用生体内線量測定（IVD）システム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・携帯型、固定型

用途別セグメントは次のように区分されます。
・医学、科学研究、その他

世界の患者用生体内線量測定（IVD）システム市場の主要な市場プレーヤーは以下のとおりです。
・Landauer、Chiyoda Technol Corporation、Mirion Technologies、Thermo Fisher Scientific、Fuji Electric、Hitachi Aloka、Bertin Instruments、Tracerco、ATOMTEX、Panasonic、Polimaster、Renri、RadPro International GmbH、Ludlum Measurements、XZ LAB

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、患者用生体内線量測定（IVD）システム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な患者用生体内線量測定（IVD）システムメーカーの企業概要、2019年～2022年までの患者用生体内線量測定（IVD）システムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な患者用生体内線量測定（IVD）システムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別患者用生体内線量測定（IVD）システムの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの患者用生体内線量測定（IVD）システムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での患者用生体内線量測定（IVD）システム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および患者用生体内線量測定（IVD）システムの産業チェーンを掲載しています。
・第13、14、15章では、患者用生体内線量測定（IVD）システムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 患者用生体内線量測定（IVD）システムの概要
- 種類別分析（2017年vs2021年vs2028年）：携帯型、固定型
- 用途別分析（2017年vs2021年vs2028年）：医学、科学研究、その他
- 世界の患者用生体内線量測定（IVD）システム市場規模・予測
- 世界の患者用生体内線量測定（IVD）システム生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Landauer、Chiyoda Technol Corporation、Mirion Technologies、Thermo Fisher Scientific、Fuji Electric、Hitachi Aloka、Bertin Instruments、Tracerco、ATOMTEX、Panasonic、Polimaster、Renri、RadPro International GmbH、Ludlum Measurements、XZ LAB
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：携帯型、固定型
・用途別分析2017年-2028年：医学、科学研究、その他
・患者用生体内線量測定（IVD）システムの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・患者用生体内線量測定（IVD）システムのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・患者用生体内線量測定（IVD）システムのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・患者用生体内線量測定（IVD）システムの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・患者用生体内線量測定（IVD）システムの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Patient In-vivo Dosimetry (IVD) System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Patient In-vivo Dosimetry (IVD) System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical accounting for % of the Patient In-vivo Dosimetry (IVD) System global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Portable segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Patient In-vivo Dosimetry (IVD) System include Landauer, Chiyoda Technol Corporation, Mirion Technologies, Thermo Fisher Scientific, and Fuji Electric, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Patient In-vivo Dosimetry (IVD) System market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Portable
Fixed
Market segment by Application can be divided into
Medical
Scientific Research
Others
The key market players for global Patient In-vivo Dosimetry (IVD) System market are listed below:
Landauer
Chiyoda Technol Corporation
Mirion Technologies
Thermo Fisher Scientific
Fuji Electric
Hitachi Aloka
Bertin Instruments
Tracerco
ATOMTEX
Panasonic
Polimaster
Renri
RadPro International GmbH
Ludlum Measurements
XZ LAB
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Patient In-vivo Dosimetry (IVD) System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Patient In-vivo Dosimetry (IVD) System, with price, sales, revenue and global market share of Patient In-vivo Dosimetry (IVD) System from 2019 to 2022.
Chapter 3, the Patient In-vivo Dosimetry (IVD) System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Patient In-vivo Dosimetry (IVD) System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Patient In-vivo Dosimetry (IVD) System market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Patient In-vivo Dosimetry (IVD) System.
Chapter 13, 14, and 15, to describe Patient In-vivo Dosimetry (IVD) System sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Patient In-vivo Dosimetry (IVD) System Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Patient In-vivo Dosimetry (IVD) System Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Portable
1.2.3 Fixed
1.3 Market Analysis by Application
1.3.1 Overview: Global Patient In-vivo Dosimetry (IVD) System Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Patient In-vivo Dosimetry (IVD) System Market Size & Forecast
1.4.1 Global Patient In-vivo Dosimetry (IVD) System Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Patient In-vivo Dosimetry (IVD) System Sales in Volume (2017-2028)
1.4.3 Global Patient In-vivo Dosimetry (IVD) System Price (2017-2028)
1.5 Global Patient In-vivo Dosimetry (IVD) System Production Capacity Analysis
1.5.1 Global Patient In-vivo Dosimetry (IVD) System Total Production Capacity (2017-2028)
1.5.2 Global Patient In-vivo Dosimetry (IVD) System Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Patient In-vivo Dosimetry (IVD) System Market Drivers
1.6.2 Patient In-vivo Dosimetry (IVD) System Market Restraints
1.6.3 Patient In-vivo Dosimetry (IVD) System Trends Analysis
2 Manufacturers Profiles
2.1 Landauer
2.1.1 Landauer Details
2.1.2 Landauer Major Business
2.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Product and Services
2.1.4 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Chiyoda Technol Corporation
2.2.1 Chiyoda Technol Corporation Details
2.2.2 Chiyoda Technol Corporation Major Business
2.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product and Services
2.2.4 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mirion Technologies
2.3.1 Mirion Technologies Details
2.3.2 Mirion Technologies Major Business
2.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product and Services
2.3.4 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product and Services
2.4.4 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Fuji Electric
2.5.1 Fuji Electric Details
2.5.2 Fuji Electric Major Business
2.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product and Services
2.5.4 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hitachi Aloka
2.6.1 Hitachi Aloka Details
2.6.2 Hitachi Aloka Major Business
2.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product and Services
2.6.4 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bertin Instruments
2.7.1 Bertin Instruments Details
2.7.2 Bertin Instruments Major Business
2.7.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product and Services
2.7.4 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Tracerco
2.8.1 Tracerco Details
2.8.2 Tracerco Major Business
2.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Product and Services
2.8.4 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ATOMTEX
2.9.1 ATOMTEX Details
2.9.2 ATOMTEX Major Business
2.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product and Services
2.9.4 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Panasonic
2.10.1 Panasonic Details
2.10.2 Panasonic Major Business
2.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Product and Services
2.10.4 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Polimaster
2.11.1 Polimaster Details
2.11.2 Polimaster Major Business
2.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Product and Services
2.11.4 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Renri
2.12.1 Renri Details
2.12.2 Renri Major Business
2.12.3 Renri Patient In-vivo Dosimetry (IVD) System Product and Services
2.12.4 Renri Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 RadPro International GmbH
2.13.1 RadPro International GmbH Details
2.13.2 RadPro International GmbH Major Business
2.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product and Services
2.13.4 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Ludlum Measurements
2.14.1 Ludlum Measurements Details
2.14.2 Ludlum Measurements Major Business
2.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product and Services
2.14.4 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 XZ LAB
2.15.1 XZ LAB Details
2.15.2 XZ LAB Major Business
2.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Product and Services
2.15.4 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Patient In-vivo Dosimetry (IVD) System Breakdown Data by Manufacturer
3.1 Global Patient In-vivo Dosimetry (IVD) System Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Patient In-vivo Dosimetry (IVD) System
3.4 Market Concentration Rate
3.4.1 Top 3 Patient In-vivo Dosimetry (IVD) System Manufacturer Market Share in 2021
3.4.2 Top 6 Patient In-vivo Dosimetry (IVD) System Manufacturer Market Share in 2021
3.5 Global Patient In-vivo Dosimetry (IVD) System Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Patient In-vivo Dosimetry (IVD) System Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Patient In-vivo Dosimetry (IVD) System Market Size by Region
4.1.1 Global Patient In-vivo Dosimetry (IVD) System Sales in Volume by Region (2017-2028)
4.1.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2028)
4.2 North America Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028)
4.3 Europe Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028)
4.4 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028)
4.5 South America Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028)
4.6 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Patient In-vivo Dosimetry (IVD) System Sales in Volume by Type (2017-2028)
5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Type (2017-2028)
5.3 Global Patient In-vivo Dosimetry (IVD) System Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Patient In-vivo Dosimetry (IVD) System Sales in Volume by Application (2017-2028)
6.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Application (2017-2028)
6.3 Global Patient In-vivo Dosimetry (IVD) System Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2028)
7.2 North America Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2028)
7.3 North America Patient In-vivo Dosimetry (IVD) System Market Size by Country
7.3.1 North America Patient In-vivo Dosimetry (IVD) System Sales in Volume by Country (2017-2028)
7.3.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2028)
8.2 Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2028)
8.3 Europe Patient In-vivo Dosimetry (IVD) System Market Size by Country
8.3.1 Europe Patient In-vivo Dosimetry (IVD) System Sales in Volume by Country (2017-2028)
8.3.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2028)
9.2 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2028)
9.3 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Market Size by Region
9.3.1 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2028)
10.2 South America Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2028)
10.3 South America Patient In-vivo Dosimetry (IVD) System Market Size by Country
10.3.1 South America Patient In-vivo Dosimetry (IVD) System Sales in Volume by Country (2017-2028)
10.3.2 South America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2028)
11.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2028)
11.3 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Market Size by Country
11.3.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Patient In-vivo Dosimetry (IVD) System and Key Manufacturers
12.2 Manufacturing Costs Percentage of Patient In-vivo Dosimetry (IVD) System
12.3 Patient In-vivo Dosimetry (IVD) System Production Process
12.4 Patient In-vivo Dosimetry (IVD) System Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Patient In-vivo Dosimetry (IVD) System Typical Distributors
13.3 Patient In-vivo Dosimetry (IVD) System Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Patient In-vivo Dosimetry (IVD) System Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Patient In-vivo Dosimetry (IVD) System Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Landauer Basic Information, Manufacturing Base and Competitors
Table 4. Landauer Major Business
Table 5. Landauer Patient In-vivo Dosimetry (IVD) System Product and Services
Table 6. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Chiyoda Technol Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Chiyoda Technol Corporation Major Business
Table 9. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product and Services
Table 10. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mirion Technologies Basic Information, Manufacturing Base and Competitors
Table 12. Mirion Technologies Major Business
Table 13. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product and Services
Table 14. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product and Services
Table 18. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Fuji Electric Basic Information, Manufacturing Base and Competitors
Table 20. Fuji Electric Major Business
Table 21. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product and Services
Table 22. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hitachi Aloka Basic Information, Manufacturing Base and Competitors
Table 24. Hitachi Aloka Major Business
Table 25. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product and Services
Table 26. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bertin Instruments Basic Information, Manufacturing Base and Competitors
Table 28. Bertin Instruments Major Business
Table 29. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product and Services
Table 30. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Tracerco Basic Information, Manufacturing Base and Competitors
Table 32. Tracerco Major Business
Table 33. Tracerco Patient In-vivo Dosimetry (IVD) System Product and Services
Table 34. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ATOMTEX Basic Information, Manufacturing Base and Competitors
Table 36. ATOMTEX Major Business
Table 37. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product and Services
Table 38. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Panasonic Basic Information, Manufacturing Base and Competitors
Table 40. Panasonic Major Business
Table 41. Panasonic Patient In-vivo Dosimetry (IVD) System Product and Services
Table 42. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Polimaster Basic Information, Manufacturing Base and Competitors
Table 44. Polimaster Major Business
Table 45. Polimaster Patient In-vivo Dosimetry (IVD) System Product and Services
Table 46. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Renri Basic Information, Manufacturing Base and Competitors
Table 48. Renri Major Business
Table 49. Renri Patient In-vivo Dosimetry (IVD) System Product and Services
Table 50. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. RadPro International GmbH Basic Information, Manufacturing Base and Competitors
Table 52. RadPro International GmbH Major Business
Table 53. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product and Services
Table 54. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Ludlum Measurements Basic Information, Manufacturing Base and Competitors
Table 56. Ludlum Measurements Major Business
Table 57. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product and Services
Table 58. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. XZ LAB Basic Information, Manufacturing Base and Competitors
Table 60. XZ LAB Major Business
Table 61. XZ LAB Patient In-vivo Dosimetry (IVD) System Product and Services
Table 62. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Patient In-vivo Dosimetry (IVD) System Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Patient In-vivo Dosimetry (IVD) System Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Patient In-vivo Dosimetry (IVD) System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Patient In-vivo Dosimetry (IVD) System Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Patient In-vivo Dosimetry (IVD) System Production Site of Key Manufacturer
Table 68. Patient In-vivo Dosimetry (IVD) System New Entrant and Capacity Expansion Plans
Table 69. Patient In-vivo Dosimetry (IVD) System Mergers & Acquisitions in the Past Five Years
Table 70. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2017-2022) & (K Units)
Table 71. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2023-2028) & (K Units)
Table 72. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 75. Global Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 76. Global Patient In-vivo Dosimetry (IVD) System Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Patient In-vivo Dosimetry (IVD) System Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Patient In-vivo Dosimetry (IVD) System Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Patient In-vivo Dosimetry (IVD) System Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 81. Global Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 82. Global Patient In-vivo Dosimetry (IVD) System Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Patient In-vivo Dosimetry (IVD) System Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Patient In-vivo Dosimetry (IVD) System Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Patient In-vivo Dosimetry (IVD) System Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)
Table 87. North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2023-2028) & (K Units)
Table 88. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 91. North America Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 92. North America Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 93. North America Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 94. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)
Table 95. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2023-2028) & (K Units)
Table 96. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 99. Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 100. Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 101. Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 110. South America Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)
Table 111. South America Patient In-vivo Dosimetry (IVD) System Sales by Country (2023-2028) & (K Units)
Table 112. South America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 115. South America Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 116. South America Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 117. South America Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2023-2028) & (K Units)
Table 126. Patient In-vivo Dosimetry (IVD) System Raw Material
Table 127. Key Manufacturers of Patient In-vivo Dosimetry (IVD) System Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Patient In-vivo Dosimetry (IVD) System Typical Distributors
Table 131. Patient In-vivo Dosimetry (IVD) System Typical Customers
List of Figures
Figure 1. Patient In-vivo Dosimetry (IVD) System Picture
Figure 2. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type in 2021
Figure 3. Portable
Figure 4. Fixed
Figure 5. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application in 2021
Figure 6. Medical
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Global Patient In-vivo Dosimetry (IVD) System Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Patient In-vivo Dosimetry (IVD) System Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Patient In-vivo Dosimetry (IVD) System Sales (2017-2028) & (K Units)
Figure 12. Global Patient In-vivo Dosimetry (IVD) System Price (2017-2028) & (US$/Unit)
Figure 13. Global Patient In-vivo Dosimetry (IVD) System Production Capacity (2017-2028) & (K Units)
Figure 14. Global Patient In-vivo Dosimetry (IVD) System Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Patient In-vivo Dosimetry (IVD) System Market Drivers
Figure 16. Patient In-vivo Dosimetry (IVD) System Market Restraints
Figure 17. Patient In-vivo Dosimetry (IVD) System Market Trends
Figure 18. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Manufacturer in 2021
Figure 19. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Manufacturer in 2021
Figure 20. Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Patient In-vivo Dosimetry (IVD) System Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Patient In-vivo Dosimetry (IVD) System Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2028)
Figure 24. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2017-2028)
Figure 25. North America Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028) & (USD Million)
Figure 26. Europe Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028) & (USD Million)
Figure 28. South America Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue (2017-2028) & (USD Million)
Figure 30. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2028)
Figure 31. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2017-2028)
Figure 32. Global Patient In-vivo Dosimetry (IVD) System Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 34. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2017-2028)
Figure 35. Global Patient In-vivo Dosimetry (IVD) System Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2028)
Figure 37. North America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 38. North America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2028)
Figure 39. North America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2028)
Figure 40. United States Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2028)
Figure 44. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 45. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2028)
Figure 46. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2028)
Figure 47. Germany Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2017-2028)
Figure 56. China Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2028)
Figure 63. South America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 64. South America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2028)
Figure 65. South America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Patient In-vivo Dosimetry (IVD) System Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Patient In-vivo Dosimetry (IVD) System in 2021
Figure 77. Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System
Figure 78. Patient In-vivo Dosimetry (IVD) System Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の表面プラズモン共鳴（SPR）システム市場2022年：市場規模予測（～2028年）
  • 世界の寛骨臼リビジョン システム市場2022年：市場規模予測（～2028年）
  • 世界の持続的気道陽圧（CPAP）システム市場2022年：市場規模予測（～2028年）
  • 世界のIPL（インテンス・パルス・ライト）システム市場2022年：市場規模予測（～2028年）
  • 世界の貨物及び車両検査 (CVI) システム市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO18217 )"世界の患者用生体内線量測定（IVD）システム市場2022年：市場規模予測（～2028年）" (英文：Global Patient In-vivo Dosimetry (IVD) System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。